Transgene Expression in Dogs after Liver-Directed Hydrodynamic Delivery of Sleeping Beauty Transposons Using Balloon Catheters

Kendra A. Hyland, Elena L. Aronovich, Erik R. Olson, Jason B. Bell, Myra Urness Rusten, Roland Gunther, David W. Hunter, Perry B. Hackett, R. Scott Mcivor

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Sleeping Beauty transposon system has been extensively tested for integration of reporter and therapeutic genes in vitro and in vivo in mice. Dogs were used as a large animal model for human therapy and minimally invasive infusion of DNA solutions. DNA solutions were delivered into the entire liver or the left side of the liver using balloon catheters for temporary occlusion of venous outflow. A peak intravascular pressure between 80 and 140 mmHg supported sufficient DNA delivery in dog liver for detection of secretable reporter proteins. Secretable reporters allowed monitoring of the time course of gene products detectable in the circulation postinfusion. Canine secreted alkaline phosphatase reporter protein levels were measured in plasma, with expression detectable for up to 6 weeks, while expression of canine erythropoietin was detectable for 7-10 days. All animals exhibited a transient increase in blood transaminases that normalized within 10 days; otherwise the treated animals were clinically normal. These results demonstrate the utility of a secreted reporter protein for real-time monitoring of gene expression in the liver in a large animal model but highlight the need for improved delivery in target tissues to support integration and long-term expression of Sleeping Beauty transposons.

Original languageEnglish (US)
Pages (from-to)541-550
Number of pages10
JournalHuman Gene Therapy
Volume28
Issue number7
DOIs
StatePublished - Jul 1 2017

Fingerprint

Beauty
Hydrodynamics
Transgenes
Catheters
Dogs
Liver
Canidae
DNA
Animal Models
Proteins
Gene Expression Profiling
Erythropoietin
Transaminases
Reporter Genes
Alkaline Phosphatase
Pressure
Therapeutics
Genes

Keywords

  • canine
  • Hydrodynamic
  • liver
  • non-viral
  • Sleeping Beauty
  • transposon

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural

Cite this

Transgene Expression in Dogs after Liver-Directed Hydrodynamic Delivery of Sleeping Beauty Transposons Using Balloon Catheters. / Hyland, Kendra A.; Aronovich, Elena L.; Olson, Erik R.; Bell, Jason B.; Rusten, Myra Urness; Gunther, Roland; Hunter, David W.; Hackett, Perry B.; Scott Mcivor, R.

In: Human Gene Therapy, Vol. 28, No. 7, 01.07.2017, p. 541-550.

Research output: Contribution to journalArticle

Hyland, Kendra A. ; Aronovich, Elena L. ; Olson, Erik R. ; Bell, Jason B. ; Rusten, Myra Urness ; Gunther, Roland ; Hunter, David W. ; Hackett, Perry B. ; Scott Mcivor, R. / Transgene Expression in Dogs after Liver-Directed Hydrodynamic Delivery of Sleeping Beauty Transposons Using Balloon Catheters. In: Human Gene Therapy. 2017 ; Vol. 28, No. 7. pp. 541-550.
@article{43172abb67d94c30acd656de85cd0a79,
title = "Transgene Expression in Dogs after Liver-Directed Hydrodynamic Delivery of Sleeping Beauty Transposons Using Balloon Catheters",
abstract = "The Sleeping Beauty transposon system has been extensively tested for integration of reporter and therapeutic genes in vitro and in vivo in mice. Dogs were used as a large animal model for human therapy and minimally invasive infusion of DNA solutions. DNA solutions were delivered into the entire liver or the left side of the liver using balloon catheters for temporary occlusion of venous outflow. A peak intravascular pressure between 80 and 140 mmHg supported sufficient DNA delivery in dog liver for detection of secretable reporter proteins. Secretable reporters allowed monitoring of the time course of gene products detectable in the circulation postinfusion. Canine secreted alkaline phosphatase reporter protein levels were measured in plasma, with expression detectable for up to 6 weeks, while expression of canine erythropoietin was detectable for 7-10 days. All animals exhibited a transient increase in blood transaminases that normalized within 10 days; otherwise the treated animals were clinically normal. These results demonstrate the utility of a secreted reporter protein for real-time monitoring of gene expression in the liver in a large animal model but highlight the need for improved delivery in target tissues to support integration and long-term expression of Sleeping Beauty transposons.",
keywords = "canine, Hydrodynamic, liver, non-viral, Sleeping Beauty, transposon",
author = "Hyland, {Kendra A.} and Aronovich, {Elena L.} and Olson, {Erik R.} and Bell, {Jason B.} and Rusten, {Myra Urness} and Roland Gunther and Hunter, {David W.} and Hackett, {Perry B.} and {Scott Mcivor}, R.",
year = "2017",
month = "7",
day = "1",
doi = "10.1089/hum.2017.003",
language = "English (US)",
volume = "28",
pages = "541--550",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "7",

}

TY - JOUR

T1 - Transgene Expression in Dogs after Liver-Directed Hydrodynamic Delivery of Sleeping Beauty Transposons Using Balloon Catheters

AU - Hyland, Kendra A.

AU - Aronovich, Elena L.

AU - Olson, Erik R.

AU - Bell, Jason B.

AU - Rusten, Myra Urness

AU - Gunther, Roland

AU - Hunter, David W.

AU - Hackett, Perry B.

AU - Scott Mcivor, R.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - The Sleeping Beauty transposon system has been extensively tested for integration of reporter and therapeutic genes in vitro and in vivo in mice. Dogs were used as a large animal model for human therapy and minimally invasive infusion of DNA solutions. DNA solutions were delivered into the entire liver or the left side of the liver using balloon catheters for temporary occlusion of venous outflow. A peak intravascular pressure between 80 and 140 mmHg supported sufficient DNA delivery in dog liver for detection of secretable reporter proteins. Secretable reporters allowed monitoring of the time course of gene products detectable in the circulation postinfusion. Canine secreted alkaline phosphatase reporter protein levels were measured in plasma, with expression detectable for up to 6 weeks, while expression of canine erythropoietin was detectable for 7-10 days. All animals exhibited a transient increase in blood transaminases that normalized within 10 days; otherwise the treated animals were clinically normal. These results demonstrate the utility of a secreted reporter protein for real-time monitoring of gene expression in the liver in a large animal model but highlight the need for improved delivery in target tissues to support integration and long-term expression of Sleeping Beauty transposons.

AB - The Sleeping Beauty transposon system has been extensively tested for integration of reporter and therapeutic genes in vitro and in vivo in mice. Dogs were used as a large animal model for human therapy and minimally invasive infusion of DNA solutions. DNA solutions were delivered into the entire liver or the left side of the liver using balloon catheters for temporary occlusion of venous outflow. A peak intravascular pressure between 80 and 140 mmHg supported sufficient DNA delivery in dog liver for detection of secretable reporter proteins. Secretable reporters allowed monitoring of the time course of gene products detectable in the circulation postinfusion. Canine secreted alkaline phosphatase reporter protein levels were measured in plasma, with expression detectable for up to 6 weeks, while expression of canine erythropoietin was detectable for 7-10 days. All animals exhibited a transient increase in blood transaminases that normalized within 10 days; otherwise the treated animals were clinically normal. These results demonstrate the utility of a secreted reporter protein for real-time monitoring of gene expression in the liver in a large animal model but highlight the need for improved delivery in target tissues to support integration and long-term expression of Sleeping Beauty transposons.

KW - canine

KW - Hydrodynamic

KW - liver

KW - non-viral

KW - Sleeping Beauty

KW - transposon

UR - http://www.scopus.com/inward/record.url?scp=85024880618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024880618&partnerID=8YFLogxK

U2 - 10.1089/hum.2017.003

DO - 10.1089/hum.2017.003

M3 - Article

C2 - 28447859

AN - SCOPUS:85024880618

VL - 28

SP - 541

EP - 550

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 7

ER -